Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€213.20

€213.20

-0.190%
-0.4
-0.190%
-

-

 
05.12.25 / Tradegate WKN: A2AJKS / Symbol: SDMHF / Name: Sartorius Stedim / Stock / Healthcare Equipment & Supplies / Large Cap /

Sartorius Stedim Biotech S.A. Stock

The price for the Sartorius Stedim Biotech S.A. stock decreased slightly today. Compared to yesterday there is a change of -€0.400 (-0.190%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Sartorius Stedim Biotech S.A. stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Sartorius Stedim Biotech S.A. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
G***** c******* t* c**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Sartorius Stedim Biotech S.A. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Sartorius Stedim Biotech S.A. -0.190% 2.747% 9.840% 21.171% 16.027% -36.661% -27.285%
bioMerieux S.A. 0.000% -2.330% -2.873% 7.487% 1.846% 7.531% -10.580%
EssilorLuxottica SA -1.710% -3.528% -5.992% 28.658% 27.230% 69.231% 134.724%
Dexcom Inc. 0.430% 2.608% 9.010% -24.574% -25.483% -49.406% -21.616%

Comments

Sartorius Stedim Biotech S.A. (OTCMKTS: SDMHF) is now covered by analysts at Jefferies Financial Group Inc.. They set a "buy" rating on the stock.
Ratings data for SDMHF provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 4.18%
Target price 54.000
Change
Ends at 25.10.17

(Zielkurs erreicht)
Show more

Prediction Buy
Perf. (%) 4.18%
Target price 54.000
Change
Ends at 25.10.17

GAP ouveture

Die GAP hat sich geöffnet heute Morgen wird zusätzlich gefüllt und hat sich der Wert bezeichnet niedriger. Es sollte abprallen

Show more

News

Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025
Sartorius Stedim Biotech publishes unaudited results for the first nine months of 2025